John Bean has been on fire lately. In the past six months alone, the company’s stock price has rocketed 46.5%, reaching $125.32 per share. This was
Over the last six months, Resideo’s shares have sunk to $17.21, producing a disappointing 5.2% loss - a stark contrast to the S&P 500’s 1.6% gain. This
Since September 2024, AECOM has been in a holding pattern, posting a small return of 0.8% while floating around $96.60.
Meritage Homes’s stock price has taken a beating over the past six months, shedding 22.2% of its value and falling to $74.61 per share. This may have
Vertex Pharmaceuticals trades at $500.94 and has moved in lockstep with the market. Its shares have returned 5.5% over the last six months while the S&P
Looking back on medical devices & supplies - specialty stocks’ Q4 earnings, we examine this quarter’s best and worst performers, including Globus Medical
Wrapping up Q4 earnings, we look at the numbers and key takeaways for the online marketplace stocks, including The RealReal (NASDAQ:REAL) and its peers.
As the Q4 earnings season wraps, let’s dig into this quarter’s best and worst performers in the professional tools and equipment industry, including
What a brutal six months it’s been for 10x Genomics. The stock has dropped 52.1% and now trades at $10.59, rattling many shareholders. This was partly
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q4. Today, we are
